Testing and reducing skindex-29 using Rasch analysis: Skindex-17.
about
Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) QuestionnaireMeasures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts.PCQoL: A Quality of Life Assessment Measure for Pachyonychia Congenita.Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional studyThe development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis Quality of Life Index (HidroQOL©).The Skindex instruments to measure the effects of skin disease on quality of lifeQuality of life in patients with leg ulcers or skin lesions - a pilot study.Measurement of health-related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life.Patient-reported outcome measures in nonmelanoma skin cancer of the face: a systematic review.Guideline for translation and national validation of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ).A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study.Facial skin pigmentation is not related to stratum corneum cohesion, basal transepidermal water loss, barrier integrity and barrier repair.Reversed thresholds in partial credit models: a reason for collapsing categories?Quality of life in postmenopausal women: translation and validation of MSkinQOL questionnaire to measure the effect of a skincare product in USA.A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.Quality of life measurement in atopic dermatitis. Position paper of the European Academy of Dermatology and Venereology (EADV) Task Force on quality of life.The Quality of Life in Hand Eczema Questionnaire (QOLHEQ): validation of the German version of a new disease-specific measure of quality of life for patients with hand eczema.Comparing the impact of psoriasis and atopic dermatitis on quality of life: co-calibration of the PSORIQoL and QoLIAD.Burden of disease during quiescent periods in patients with pemphigus.Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva.Development and preliminary validation of the PC-SAD5, a screener-derived short depression severity measure.The reduced Impact of Psoriasis Questionnaire has good psychometric properties in Italian patients.Improving Measures via Examining the Behavior of Distractors in Multiple-Choice Tests: Assessment and Remediation.The Rasch Rating Model and the Disordered Threshold Controversy
P2860
Q21133692-300DB546-A216-4039-8DDA-6401586C287DQ27021322-FD8401B6-5502-47D2-8C8D-6E511BAD7011Q33825878-7BA9D329-8191-4C8E-8DE4-4C197CB21C5FQ34467382-1D9F541C-BC88-46FE-B76F-7D7556C903F3Q35019187-7F8ED4CC-8026-4040-AD00-1D439E0F4719Q35197161-CA7E5AB8-B634-4DCA-AD2C-E109F13CF43BQ35714588-62380D35-CA46-482A-B85D-D5A3DD8E627BQ36418886-C2FAFE7F-6A14-42D9-908A-96377B856A3CQ38072725-A75C377D-3F97-484B-AE2E-172486E8226AQ38079608-ABABA448-0AD8-4770-9CC2-C4169909DF42Q38798674-20D166FE-D1C7-4A91-BEA8-C417A49B597CQ39601823-A37982DE-8CD9-4B2A-95F3-9E6CF13BF1E3Q41720246-83EDAE71-9A53-44CF-8ADC-8C6EF831117EQ45728606-0967F4FD-4185-42BB-B524-6D6686571BCFQ46909352-81868E65-DFD1-449D-9CE8-EB61151F75F9Q47586627-EAE6B755-BF22-4AA3-B7BD-3F068F307DC4Q47616404-D428DE0D-8E03-4082-B913-BAE6C3AE1BCCQ47933293-03FCBBB6-D3BD-46E7-B1F4-8B251953AADEQ48087641-B178D6C9-C2E8-4B62-B5E0-3054B1657AF4Q48096667-08D564B6-5C46-4396-8A4A-4FB49F5E5FFEQ48569928-84AB7261-220A-4A59-AE0E-322E8AF415D3Q48893536-6F763EED-3301-42D6-BFC5-E952FDF3D800Q53174190-2597FBF1-93DF-4162-917E-146AFC289032Q55042796-4110EA41-5216-4D91-ACA9-90D60D2B0595Q58297843-0AFDB26A-536C-461A-8401-CF38FF3B8668
P2860
Testing and reducing skindex-29 using Rasch analysis: Skindex-17.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Testing and reducing skindex-29 using Rasch analysis: Skindex-17.
@en
Testing and reducing skindex-29 using Rasch analysis: Skindex-17.
@nl
type
label
Testing and reducing skindex-29 using Rasch analysis: Skindex-17.
@en
Testing and reducing skindex-29 using Rasch analysis: Skindex-17.
@nl
prefLabel
Testing and reducing skindex-29 using Rasch analysis: Skindex-17.
@en
Testing and reducing skindex-29 using Rasch analysis: Skindex-17.
@nl
P2093
P356
P1476
Testing and reducing skindex-29 using Rasch analysis: Skindex-17.
@en
P2093
Francesca Sampogna
Mary-Margaret Chren
Tamar E C Nijsten
P2888
P304
P356
10.1038/SJ.JID.5700212
P407
P577
2006-06-01T00:00:00Z